Thrombin-activatable fibrinolysis inhibitor (TAFI) is enhanced in major trauma patients without infectious complications
Authors:
- B. ReljaBRB. Relja
- T. LustenbergerTLT. Lustenberger
- B. PuttkammerBPB. Puttkammer
- H. JakobHJH. Jakob
- J. MorserJMJ. Morser
- E.C. GabazzaEGE.C. Gabazza
- Y. TakeiYTY. Takei
- I. MarziIMI. Marzi
Open Access
- 1 April 2013
- journal article
- clinical trial
- Published by Elsevier in Immunobiology
- Vol. 218 (4) , 470-476
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Early detection of severe sepsis in the emergency room: Diagnostic value of plasma C-reactive protein, procalcitonin, and interleukin-6Scandinavian Journal of Infectious Diseases, 2011
- Early predictors of morbidity and mortality in trauma patients treated in the intensive care unitActa Anaesthesiologica Scandinavica, 2010
- What has been learnt from the thrombin-activatable fibrinolysis inhibitor-deficient mouse?Journal of Thrombosis and Haemostasis, 2010
- Carboxypeptidase U (TAFIa): a new drug target for fibrinolytic therapy?Journal of Thrombosis and Haemostasis, 2009
- Metabolic Modulation of Inflammation-Induced Activation of CoagulationSeminars in Thrombosis and Hemostasis, 2008
- Plasma Thrombin Activatable Fibrinolysis Inhibitor and Tissue Factor Pathway Inhibitor Changes Following SepsisClinical and Applied Thrombosis/Hemostasis, 2007
- The interactions between inflammation and coagulationBritish Journal of Haematology, 2005
- Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndromeThe Journal of Pathology, 2003
- Calcitonin precursors are reliable markers of sepsis in a medical intensive care unitCritical Care Medicine, 2000
- TAFI, or Plasma Procarboxypeptidase B, Couples the Coagulation and Fibrinolytic Cascades through the Thrombin-Thrombomodulin ComplexJournal of Biological Chemistry, 1996